TITAN PHARMACEUTICALS INC — Director's Dealing 2017

Feb 14, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TITAN PHARMACEUTICALS INC (TTNP)
CIK: 0000910267
Period of Report: 2017-02-13

Reporting Person: Rubin Marc (Director, Executive Chairman)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-02-13	Option to Purchase Common Stock	$3.90	A	70000	Acquired	2027-02-13	Common Stock (70000)	Direct

Footnotes

F1: The options vest in 24 equal monthly installments commencing on the grant date.